CLOVER HEALTH INVESTMENTS CO (CLOV) Stock Analyst Earnings Estimates
NASDAQ:CLOV - Nasdaq - US18914F1030 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.472B | 3.477B 136.19% | 2.034B -41.50% | 1.548B -23.88% | 1.75B 13.05% | 1.915B 9.43% | 2.008B 4.86% | 2.559B 27.44% | 3.629B 41.81% | 4.445B 22.49% | 5.334B 20.00% | |
| EBITDA YoY % growth | -635.75M -1,056.16% | -369.71M 41.85% | -180.157M 51.27% | 58.442M 132.44% | 52.079M -10.89% | 97.657M 87.52% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -637M -9,131.88% | -370.9M 41.77% | -182.666M 50.75% | -59.08M 67.66% | -39.588M 32.99% | -2.392M 93.96% | N/A | 130.64M | 199.59M 52.78% | 288.95M 44.77% | 400.08M 38.46% | |
| Operating Margin | -43.27% | -10.67% | -8.98% | -3.82% | -2.26% | -0.12% | N/A | 5.11% | 5.50% | 6.50% | 7.50% | |
| EPS YoY % growth | -1.27 2.91% | -0.74 41.52% | -0.44 40.94% | -0.12 72.76% | -0.14 -17.02% | -0.11 22.42% | 0.10 193.75% | 0.17 70.00% | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.07 52.64% | -0.05 -14.75% | -0.01 -176.50% | -0.03 -27.50% | -0.06 7.69% | -0.02 55.56% | -0.01 -33.33% | -0.01 60.00% | -0.06 |
| Revenue Q2Q % growth | 390.2M -23.53% | 438.42M 26.37% | 442.78M 24.29% | 429.92M 29.89% | 441.38M 13.12% | 496.83M 13.32% | 515.72M 16.47% | 487.69M 13.44% | 521.15M 18.07% |
| EBITDA Q2Q % growth | -5.089M 88.73% | 7.661M 134.77% | 26.513M 219.13% | 18.37M 320.37% | -756.84K 85.13% | 21.124M 175.73% | 26.816M 1.14% | 26.071M 41.92% | 489.6K 164.69% |
| EBIT Q2Q % growth | -26.834M 43.69% | -15.546M 30.44% | 3.644M -52.43% | -4.492M 51.82% | -23.195M 13.56% | 20.788M 233.72% | 26.469M 626.37% | 25.724M 672.65% | 153K 100.66% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.02 77.78% | -0.04 | 0.02 | 50.98% |
| Q2 2024 Q2Q % growth | 0.01 116.67% | -0.05 | 0.06 | 120.14% |
| Q1 2024 Q2Q % growth | -0.04 73.33% | -0.07 | 0.03 | 45.78% |
| Q4 2023 Q2Q % growth | -0.14 20.00% | -0.14 | 0.00 | 1.49% |
| Q3 2023 Q2Q % growth | -0.09 43.75% | -0.11 | 0.02 | 16.50% |
| Q2 2023 Q2Q % growth | -0.06 72.73% | -0.15 | 0.09 | 60.89% |
| Q1 2023 Q2Q % growth | -0.15 21.05% | -0.18 | 0.03 | 16.35% |
| Q4 2022 Q2Q % growth | -0.18 38.38% | -0.26 | 0.09 | 32.77% |
| Q3 2022 Q2Q % growth | -0.16 -100.00% | -0.24 | 0.08 | 34.37% |
| Q2 2022 Q2Q % growth | -0.22 71.79% | -0.21 | -0.01 | -4.60% |
| Q1 2022 Q2Q % growth | -0.19 -46.15% | -0.28 | 0.09 | 31.87% |
| Q4 2021 Q2Q % growth | -0.28 -42.00% | -0.27 | -0.02 | -5.80% |
| Q3 2021 Q2Q % growth | -0.08 | -0.23 | 0.15 | 65.64% |
| Q2 2021 Q2Q % growth | -0.78 | -0.14 | -0.64 | -465.07% |
| Q1 2021 Q2Q % growth | -0.13 | -0.11 | -0.02 | -15.16% |
| Q4 2020 Q2Q % growth | -0.20 | -0.86 | 0.66 | 76.66% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 330.986M -31.34% | 353.2M | -22.214M | -6.29% |
| Q2 2024 Q2Q % growth | 356.26M -30.64% | 345.54M | 10.72M | 3.10% |
| Q1 2024 Q2Q % growth | 346.922M -34.27% | 327.65M | 19.272M | 5.88% |
| Q4 2023 Q2Q % growth | 510.251M -43.23% | 489.86M | 20.391M | 4.16% |
| Q3 2023 Q2Q % growth | 482.066M -43.74% | 504.49M | -22.424M | -4.44% |
| Q2 2023 Q2Q % growth | 513.628M -39.34% | 500.64M | 12.988M | 2.59% |
| Q1 2023 Q2Q % growth | 527.775M -39.64% | 508.71M | 19.065M | 3.75% |
| Q4 2022 Q2Q % growth | 898.8M 108.06% | 801.09M | 97.71M | 12.20% |
| Q3 2022 Q2Q % growth | 856.8M 100.56% | 815.45M | 41.35M | 5.07% |
| Q2 2022 Q2Q % growth | 846.7M 105.26% | 830.91M | 15.79M | 1.90% |
| Q1 2022 Q2Q % growth | 874.4M 336.55% | 803.16M | 71.24M | 8.87% |
| Q4 2021 Q2Q % growth | 432M | 416.3M | 15.7M | 3.77% |
| Q3 2021 Q2Q % growth | 427.2M | 421.36M | 5.84M | 1.39% |
| Q2 2021 Q2Q % growth | 412.5M | 209.49M | 203.01M | 96.91% |
| Q1 2021 Q2Q % growth | 200.3M | 196.42M | 3.88M | 1.98% |
| Q4 2020 Q2Q % growth | 170.3M | -170.3M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.5% | 2.5% | -0.71% | 9.62% |
| Revenue | 9.92% | 11.08% | 0% | 9.71% |